Glycanated human endocan has been shown to strongly promote tumor growth (86) through its ability to bind to the integrin CD11a/CD18 (LFA-1) and thus to block leukocyte binding to endothelium and subsequent infiltration to tumor tissues (87); or through its promotion of growth factor actions (83, 88). Here, ITGAL is linked to neoplasm.